Background
Methods
Results
Conclusions
Key Words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesReferences
Global burden of stroke. Available at: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf). Accessed December 22, 2008.
- Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.Eur Heart J. 2006; 27: 949-953
- Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.Circulation. 1998; 98: 946-952
- Atherosclerosis: an inflammatory disease.N Engl J Med. 1999; 340: 115
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.Thorax. 2004; 59: 574-580
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.Eur Respir J. 2008; 32: 962-969
- Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study.Am J Respir Crit Care Med. 2013; 188: 783-788
- Trends and cardiovascular co-morbidities of COPD subjects in the Veterans Administration Medical System, 1991-1999.COPD. 2005; 2: 35-41
- Increased risk of myocardial infarction and stroke following exacerbation of COPD.Chest. 2010; 137: 1091-1097
- Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.Thorax. 2010; 65: 956-962
- Inhaled anticholinergics and risk of major adverse cardiovascular events in subjects with chronic obstructive pulmonary disease.JAMA. 2008; 300: 143
- Why are subjects with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.Circulation. 2003; 107: 1514-1519
- Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.Int J Cardiol. 2012; 158: 279-284
Article info
Publication history
Footnotes
R.N. contributed substantially to the conception and design of the work, and acquisition, analysis, and interpretation of data. He also drafted the article, and revised and approved the final version of the draft. A.S. contributed substantially to the conception of the work, and acquisition, analysis, and interpretation of data. He revised and approved the final version of the draft. S.T. contributed substantially to the design of the work, and acquisition, analysis, and interpretation of data. She also revised and approved the final version of the draft. H.S. contributed substantially to the design of the work, and acquisition, analysis, and interpretation of data. He also revised and approved the final version of the draft. J.M. contributed substantially to the design of the work, and acquisition, analysis, and interpretation of data. He also revised and approved the final version of the draft. A.N. contributed substantially to the design of the work, and acquisition and interpretation of data. He also critically reviewed the article, and revised and approved the final version of the draft.
All investigators have no personal or financial associations with any entity with an interest in the subject matter of this study. There exists no conflict of interest for any of the authors.
No funding was provided from any institution.
Identification
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.034
